▟ Vinebot intrinsic value, daily

← back

CTSH Cognizant

software · valued with opus medium conviction · deep-dived 2026-10-16

STRONG BUY
Intrinsic value$61.23
Price (at call)$65.77
Margin of safety -6.9%
vs market (rating basis) +50.0%

Mature, cash-rich IT services firm fairly priced; AI is both a threat and a tailwind.

The story

Cognizant is a scaled IT services and outsourcing firm (digital engineering, cloud, BPO) with deep enterprise relationships in healthcare and financial services, giving it sticky multi-year contracts but little pricing power. It is a mature business: growth has been low single digits for five years, with a recent bump from acquisitions (Belcan) and large deals. Generative AI is a double-edged sword, opening new integration work while compressing labor-based pricing.

Year-one growth of 5% reflects current deal momentum and acquisitions, fading to 2.5% terminal growth, consistent with the 2.8% five-year CAGR. The margin is set at 15.8%, slightly below the TTM 16.4% peak and in line with the 15-16% historical band, because of AI-driven pricing pressure and wage inflation. Sales-to-capital of 1.5 is close to the reported 1.39, and the beta of 1.05 fits a cash-rich, net-cash services firm.

Value drivers

Revenue growth (Y1)5.0%
Terminal growth2.5%
Forecast horizon6y
Target operating margin15.8%
Years to target margin3
Sales-to-capital1.50
Beta1.05
Failure probability1.0%
Cost of capital (WACC)9.7%
Terminal WACC9.5%

Valuation bridge

PV of explicit FCFF8.58B
PV of terminal value19.35B
Equity value28.96B
÷ shares → per share$61.23

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 22.72B 5.0% 16.2% 2.39B 721.40M 1.67B 1.52B
2 23.75B 4.5% 16.0% 2.47B 681.72M 1.79B 1.48B
3 24.70B 4.0% 15.8% 2.54B 633.24M 1.90B 1.44B
4 25.56B 3.5% 15.8% 2.63B 576.25M 2.05B 1.41B
5 26.33B 3.0% 15.8% 2.70B 511.22M 2.19B 1.38B
6 26.99B 2.5% 15.8% 2.77B 438.80M 2.33B 1.34B

Key risks

  • GenAI automation deflating headcount-based billing and pricing
  • Client concentration in healthcare/financial services discretionary spending
  • Wage inflation and attrition squeezing margins against Accenture/Indian peers

Catalysts

  • Large multi-year managed-services and AI integration deal wins
  • Sustained buybacks and dividends from net-cash balance sheet

History

DatePriceIntrinsicMoSRating
2026-10-16$65.77 $61.23 -6.9% STRONG BUY
2026-09-11$58.32 $71.86 +23.2% STRONG BUY
2026-08-10$57.67 $75.89 +31.6% STRONG BUY
2026-07-03$41.99 $65.94 +57.0% STRONG BUY
2026-06-23$40.95 $65.19 +59.2% STRONG BUY